Stem Cell Therapy Market Size, Share, Growth Trends, Industry Analysis and Forecast to 2030
Report ID: RC145508 | Report Format: PDF + Excel | Last Updated: September 4th, 2025The global stem cell therapy market size was valued at around USD 450 million in 2024 and expected to grow at a significant CAGR around 25% over the forecast period from 2025 to 2030. The rising incidence of chronic disease across the globe is a primary factor to drive the market growth. Rapid growth in the rate of cancer is further propelling the market. According to the latest information shared by the American Cancer Society, it is estimated that 1.8 million new cases were diagnosed in 2020, and 606,520 deaths recorded due to cancer in the United States.
Furthermore, the increasing investment in research and development activities and an increase in technological advances for conducting advanced stem cell-based therapies are projected to uplift the market growth. However, the strict guideline for the clinical trial, regulatory challenges associated with the approval, and operation cost related to the manufacturing process are some factors to restrain the market growth.
Report Attributes
| Benchmark Year | 2024 | ||
| Market Size | ~ USD 450 Million | ||
| Market Growth (CAGR) | > 25% (2025-2030) | ||
| Largest Market Share | North America | ||
| Analysis Period | 2020-2030 | ||
| Market Players | Celgene Corporation, Virgin Health Bank, ReNeuron Group plc, Biovault Family, and Mesoblast Ltd. |
Stem Cell Therapy Market Driving Factors:
The stem cell therapy market is primarily driven by the rising prevalence of chronic diseases and degenerative conditions such as cancer, diabetes, cardiovascular disorders, and neurodegenerative diseases. Stem cell therapies offer unique regenerative potential by repairing or replacing damaged tissues, making them a promising solution where conventional treatments often fail. The growing geriatric population, which is more prone to these conditions, is further fueling demand for innovative therapies. Additionally, increasing awareness about the therapeutic benefits of stem cells and their ability to improve patient outcomes is contributing to market expansion.
Another key driver is the rapid progress in biotechnology, research funding, and supportive regulatory frameworks. Advances in cell culture, cryopreservation, and stem cell differentiation techniques have enhanced the effectiveness and safety of stem cell therapies, accelerating clinical adoption. Governments and private organizations are investing heavily in regenerative medicine research, while regulatory agencies are providing fast-track designations and approvals for promising stem cell-based treatments. Furthermore, the growth of stem cell banking services and the increasing number of clinical trials worldwide are creating a robust foundation for market growth, paving the way for broader commercialization of therapies.
Industry Trends Shaping the Stem Cell Therapy Market:
The stem cell therapy market is experiencing a strong trend toward the commercialization of allogeneic stem cell therapies due to their scalability and cost-effectiveness compared to autologous treatments. Allogeneic therapies, derived from donor cells, can be mass-produced and made readily available, reducing treatment delays and costs. This is fueling investment from biopharmaceutical companies and encouraging partnerships for large-scale clinical trials. Additionally, the rising focus on off-the-shelf stem cell products is accelerating the development of standardized, widely accessible therapies for conditions ranging from orthopedic injuries to neurodegenerative diseases.
Another key trend is the integration of advanced technologies such as gene editing, 3D bioprinting, and AI in stem cell research and therapy development. CRISPR-based editing is being used to enhance stem cell functionality, while 3D bioprinting is enabling the creation of tissue and organ structures for transplantation. AI and big data analytics are improving patient selection, predicting therapy outcomes, and optimizing clinical trial designs. Alongside these innovations, personalized stem cell therapies tailored to individual genetic profiles are gaining traction, reflecting the growing convergence of regenerative medicine and precision medicine.
Stem Cell Therapy Market Opportunities:
The stem cell therapy market presents significant opportunities in the expansion of therapeutic applications across a wide range of diseases. Beyond well-established uses in oncology and hematology, stem cell therapies are increasingly being explored for cardiovascular, orthopedic, neurological, and autoimmune disorders. The rising incidence of conditions such as Parkinson’s disease, spinal cord injuries, and type 1 diabetes creates a vast unmet need that stem cell-based solutions can address. Companies that invest in diversifying clinical pipelines and targeting these high-burden diseases have the potential to capture substantial market share while offering transformative treatment options.
Another major opportunity lies in the growth of stem cell banking and international collaborations for clinical research. The increasing trend of umbilical cord blood banking and induced pluripotent stem cell (iPSC) banking is providing a readily available source of stem cells for future therapies. This, coupled with cross-border partnerships between research institutions, biotech firms, and healthcare providers, is accelerating the translation of laboratory research into commercialized therapies. Emerging markets in Asia-Pacific and Latin America, with improving healthcare infrastructure and rising investments in regenerative medicine, offer fertile ground for expansion, creating new pathways for companies to scale globally.
Market Segments Insights:
The global stem cell therapy market is bifurcated into type, application, cell source, end-user, and geography. On the basis of type, the market is further segmented into allogeneic and autologous stem cell therapy. The allogeneic segment held the largest market share and accounted to hold a major market share around 55% of the market. Furthermore, the autologous segment is expected to grow at the fastest growth rate over the forecast period due to the low risk of complications. Moreover, the segment growth is further attributed to the affordability, improved survival rate of patients, and no risk of graft-versus-host diseases.
By cell source, the stem cell therapy market is further divided into adipose tissue-derived mesenchymal, bone marrow-derived mesenchymal, cord blood/embryonic, and other stem cells. The adipose tissue-derived mesenchymal segment is accounted to hold a significant market share in terms of revenue. The segment growth is attributed to the increasing demand for accessible and easy stem cell sources. Furthermore, the bone marrow-derived mesenchymal segment is expected to grow at the fastest growth rate over the forecast period.
The stem cell therapy comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.
Stem Cell Therapy Market Segmentation
By Type:
- Allogeneic Stem Cell Therapy
- Autologous Stem Cell Therapy
By Application:
- Regenerative Medicine
- Orthopedics
- Neurology
- Hematology stem cells
- Soft tissue injuries
- Cardiovascular and myocardial infarction-based
- Oncology
- Diabetes
- Liver Disorder
- Others
- Drug discovery & development
By Cell Source:
- Adipose Tissue-Derived Mesenchymal Stem Cells
- Bone Marrow-Derived Mesenchymal Stem Cells
- Cord Blood/Embryonic Stem Cells
- Others
By End-User:
- Clinics
- Hospitals
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Geographic Coverage
Geographically, the stem cell therapy market report comprises dedicated sections centering on the regional market revenue and trends. The market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. The market estimates have also been provided for the historical years along with forecasts for the period from 2025 – 2030.
Stem Cell Therapy Market Competition Assessment
Key players operating in the global stem cell therapy market are Celgene Corporation, Virgin Health Bank, ReNeuron Group plc, Biovault Family, and Mesoblast Ltd. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.
Key Companies
- Celgene Corporation
- Virgin Health Bank
- ReNeuron Group plc
- Biovault Family
- Mesoblast Ltd.
- Precious Cells International Ltd.
- Caladrius
- Opexa Therapeutics, Inc.
- Neuralstem, Inc.
- Pluristem
Key Questions Answered by Stem Cell Therapy Market Report:
- Global stem cell therapy market forecasts from 2021-2027
- Regional stem cell therapy market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
- Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
- Stem cell therapy submarket forecasts from 2021-2027 covering the market by type, by application, by cell source, by end-user, and geography
- Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
- Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2021-2027
- Competitive Landscape and market positioning of top 10 players operating in the market
1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions
2. Executive Summary
2.1. Global Stem Cell Therapy Market Portraiture
2.2. Global Stem Cell Therapy Market, by Type, 2020 (USD Mn)
2.3. Global Stem Cell Therapy Market, by Application, 2020 (USD Mn)
2.4. Global Stem Cell Therapy Market, by Cell Source, 2020 (USD Mn)
2.5. Global Stem Cell Therapy Market, by End-User, 2020 (USD Mn)
2.6. Global Stem Cell Therapy Market, by Geography, 2020 (USD Mn)
3. Global Stem Cell Therapy Market Analysis
3.1. Stem Cell Therapy Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery
4. Global Stem Cell Therapy Market By Type, 2018 – 2027 (USD Mn)
4.1. Overview
4.2. Allogeneic Stem Cell Therapy
4.3. Autologous Stem Cell Therapy
5. Global Stem Cell Therapy Market By Application, 2018 – 2027 (USD Mn)
5.1. Overview
5.2. Regenerative Medicine
5.2.1. Orthopedics
5.2.2. Neurology
5.2.3. Hematology stem cells
5.2.4. Soft tissue injuries
5.2.5. Cardiovascular and myocardial infarction-based
5.2.6. Oncology
5.2.7. Diabetes
5.2.8. Liver Disorder
5.2.9. Others
5.3. Drug discovery & development
6. Global Stem Cell Therapy Market By Cell Source, 2018 – 2027 (USD Mn)
6.1. Overview
6.2. Adipose Tissue-Derived Mesenchymal Stem Cells
6.3. Bone Marrow-Derived Mesenchymal Stem Cells
6.4. Cord Blood/Embryonic Stem Cells
6.5. Others
7. Global Stem Cell Therapy Market By End-User, 2018 – 2027 (USD Mn)
7.1. Overview
7.2. Clinics
7.3. Hospitals
7.4. Others
8. North America Stem Cell Therapy Market Analysis and Forecast, 2018 – 2027 (USD Mn)
8.1.1. Overview
8.1.2. North America Stem Cell Therapy Market by Type (2018-2027 USD Mn)
8.1.3. North America Stem Cell Therapy Market by Application (2018-2027 USD Mn)
8.1.4. North America Stem Cell Therapy Market by Cell Source (2018-2027 USD Mn)
8.1.5. North America Stem Cell Therapy Market by End-User (2018-2027 USD Mn)
8.1.6. North America Stem Cell Therapy Market by Country (2018-2027 USD Mn)
8.1.6.1. U.S.
8.1.6.2. Canada
9. Europe Stem Cell Therapy Market Analysis and Forecast, 2018 – 2027 (USD Mn)
9.1.1. Overview
9.1.2. Europe Stem Cell Therapy Market by Type (2018-2027 USD Mn)
9.1.3. Europe Stem Cell Therapy Market by Application (2018-2027 USD Mn)
9.1.4. Europe Stem Cell Therapy Market by Cell Source (2018-2027 USD Mn)
9.1.5. Europe Stem Cell Therapy Market by End-User (2018-2027 USD Mn)
9.1.6. Europe Stem Cell Therapy Market by Country (2018-2027 USD Mn)
9.1.6.1. Germany
9.1.6.2. U.K.
9.1.6.3. France
9.1.6.4. Italy
9.1.6.5. Rest of Europe
10. Asia Pacific Stem Cell Therapy Market Analysis and Forecast, 2018 – 2027 (USD Mn)
10.1.1. Overview
10.1.2. Asia Pacific Stem Cell Therapy Market by Type (2018-2027 USD Mn)
10.1.3. Asia Pacific Stem Cell Therapy Market by Application (2018-2027 USD Mn)
10.1.4. Asia Pacific Stem Cell Therapy Market by Cell Source (2018-2027 USD Mn)
10.1.5. Asia Pacific Stem Cell Therapy Market by End-User (2018-2027 USD Mn)
10.1.6. Asia Pacific Stem Cell Therapy Market by Country (2018-2027 USD Mn)
10.1.6.1. China.
10.1.6.2. Japan
10.1.6.3. Rest of Asia Pacific
11. Latin America (LATAM) Stem Cell Therapy Market Analysis and Forecast, 2018 – 2027 (USD Mn)
11.1.1. Overview
11.1.2. Latin America Stem Cell Therapy Market by Type (2018-2027 USD Mn)
11.1.3. Latin America Stem Cell Therapy Market by Application (2018-2027 USD Mn)
11.1.4. Latin America Stem Cell Therapy Market by Cell Source (2018-2027 USD Mn)
11.1.5. Latin America Stem Cell Therapy Market by End-User (2018-2027 USD Mn)
11.1.6. Latin America Stem Cell Therapy Market by Country (2018-2027 USD Mn)
11.1.6.1. Brazil
11.1.6.2. Mexico
11.1.6.3. Rest of Latin America
12. Middle East and Africa Stem Cell Therapy Market Analysis and Forecast, 2018 – 2027 (USD Mn)
12.1.1. Overview
12.1.2. MEA Stem Cell Therapy Market by Type (2018-2027 USD Mn)
12.1.3. MEA Stem Cell Therapy Market by Application (2018-2027 USD Mn)
12.1.4. MEA Stem Cell Therapy Market by Cell Source (2018-2027 USD Mn)
12.1.5. MEA Stem Cell Therapy Market by End-User (2018-2027 USD Mn)
12.1.6. Middle East and Africa Stem Cell Therapy Market, by Country (2018-2027 USD Mn)
12.1.6.1. GCC
12.1.6.2. Rest of MEA
13. Company Profiles
13.1. Celgene Corporation
13.1.1. Business Description
13.1.2. Financial Health and Budget Allocation
13.1.3. Product Positions/Portfolio
13.1.4. Recent Development
13.1.5. SWOT Analysis
13.2. Virgin Health Bank
13.2.1. Business Description
13.2.2. Financial Health and Budget Allocation
13.2.3. Product Positions/Portfolio
13.2.4. Recent Development
13.2.5. SWOT Analysis
13.3. ReNeuron Group plc
13.3.1. Business Description
13.3.2. Financial Health and Budget Allocation
13.3.3. Product Positions/Portfolio
13.3.4. Recent Development
13.3.5. SWOT Analysis
13.4. Biovault Family
13.4.1. Business Description
13.4.2. Financial Health and Budget Allocation
13.4.3. Product Positions/Portfolio
13.4.4. Recent Development
13.4.5. SWOT Analysis
13.5. Mesoblast Ltd.
13.5.1. Business Description
13.5.2. Financial Health and Budget Allocation
13.5.3. Product Positions/Portfolio
13.5.4. Recent Development
13.5.5. SWOT Analysis
13.6. Precious Cells International Ltd.
13.6.1. Business Description
13.6.2. Financial Health and Budget Allocation
13.6.3. Product Positions/Portfolio
13.6.4. Recent Development
13.6.5. SWOT Analysis
13.7. Caladrius
13.7.1. Business Description
13.7.2. Financial Health and Budget Allocation
13.7.3. Product Positions/Portfolio
13.7.4. Recent Development
13.7.5. SWOT Analysis
13.8. Opexa Therapeutics, Inc.
13.8.1. Business Description
13.8.2. Financial Health and Budget Allocation
13.8.3. Product Positions/Portfolio
13.8.4. Recent Development
13.8.5. SWOT Analysis
13.9. Neuralstem, Inc.
13.9.1. Business Description
13.9.2. Financial Health and Budget Allocation
13.9.3. Product Positions/Portfolio
13.9.4. Recent Development
13.9.5. SWOT Analysis
13.10. Pluristem
13.10.1. Business Description
13.10.2. Financial Health and Budget Allocation
13.10.3. Product Positions/Portfolio
13.10.4. Recent Development
13.10.5. SWOT Analysis
To know more about the study, request a report sample
List of Tables:
TABLE 1 Market Snapshot: Global Stem Cell Therapy Market
TABLE 2 Impact Indicators
TABLE 3 Impact Analysis of Drivers and Challenges
TABLE 4 Global Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 5 Global Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 6 Global Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 7 Global Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 8 North America Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 9 North America Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 10 North America Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 11 North America Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 12 North America Stem Cell Therapy Market Value, By Country, 2018 - 2027 (US$ Mn)
TABLE 13 U.S. Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 14 U.S. Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 15 U.S. Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 16 U.S. Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 17 Canada Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 18 Canada Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 19 Canada Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 20 Canada Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 21 Europe Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 22 Europe Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 23 Europe Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 24 Europe Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 25 Europe Stem Cell Therapy Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 26 Germany Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 27 Germany Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 28 Germany Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 29 Germany Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 30 U.K. Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 31 U.K. Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 32 U.K. Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 33 U.K. Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 34 France Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 35 France Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 36 France Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 37 France Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 38 Italy Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 39 Italy Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 40 Italy Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 41 Italy Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 42 Rest of Europe Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 43 Rest of Europe Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 43 Rest of Europe Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 44 Rest of Europe Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 45 Asia Pacific Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 46 Asia Pacific Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 47 Asia Pacific Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 48 Asia Pacific Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 49 Asia Pacific Stem Cell Therapy Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 50 Japan Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 51 Japan Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 52 Japan Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 53 Japan Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 54 China Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 55 China Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 56 China Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 57 China Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 58 Rest of Asia Pacific Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 59 Rest of Asia Pacific Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 60 Rest of Asia Pacific Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 61 Rest of Asia Pacific Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 62 Latin America Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 63 Latin America Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 64 Latin America Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 65 Latin America Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 66 Latin America Stem Cell Therapy Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 67 Brazil Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 68 Brazil Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 69 Brazil Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 70 Brazil Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 71 Mexico Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 72 Mexico Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 73 Mexico Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 74 Mexico Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 75 Rest of Latin America Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 76 Rest of Latin America Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 77 Rest of Latin America Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 78 Rest of Latin America Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 79 Middle East & Africa Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 80 Middle East & Africa Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 81 Middle East & Africa Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 82 Middle East & Africa Stem Cell Therapy Market Value, by End-User, 2018 - 2027 (US$ Mn)
TABLE 83 Middle East & Africa Stem Cell Therapy Market Value, by Country, 2018 - 2027 (US$ Mn)
TABLE 84 GCC Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 85 GCC Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 86 GCC Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 87 GCC Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 88 Rest of MEA Stem Cell Therapy Market Value, by Type, 2018 - 2027 (US$ Mn)
TABLE 89 Rest of MEA Stem Cell Therapy Market Value, by Application, 2018 - 2027 (US$ Mn)
TABLE 90 Rest of MEA Stem Cell Therapy Market Value, by Cell Source, 2018 - 2027 (US$ Mn)
TABLE 91 Rest of MEA Stem Cell Therapy Market Value, by End-user, 2018 - 2027 (US$ Mn)
TABLE 92 Celgene Corporation: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 93 Virgin Health Bank: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 94 ReNeuron Group plc: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 95 Biovault Family: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 96 Mesoblast Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 97 Precious Cells International Ltd.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 98 Caladrius: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 99 Opexa Therapeutics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 100 Neuralstem, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
TABLE 101 Pluristem: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent Developments)
To know more about the study, request a report sample
List of Figures:
FIG. 1 Global Stem Cell Therapy: Market Segmentation
FIG. 2 Global Stem Cell Therapy Market: Research Methodology
FIG. 3 Top-Down and Bottom-up Approach
FIG. 4 Global Stem Cell Therapy Market, by Type, 2019 (US$ Mn)
FIG. 5 Global Stem Cell Therapy Market, by Application, 2019 (US$ Mn)
FIG. 6 Global Stem Cell Therapy Market, by Cell Source, 2019 (US$ Mn)
FIG. 7 Global Stem Cell Therapy Market, by End-User, 2019 (US$ Mn)
FIG. 8 Global Stem Cell Therapy Market, by Geography, 2019 (US$ Mn)
FIG. 9 Global Stem Cell Therapy Market Value and Growth, 2018 – 2027, (US$ Mn) (Y-o-Y %)
FIG. 10 Attractive Investment Proposition, by Geography, 2017
FIG. 11 Market Positioning of Key Stem Cell Therapy Providers, 2019
FIG. 12 Global Stem Cell Therapy Market Value Share, by Type, 2018 & 2027 (%)
FIG. 13 Global Stem Cell Therapy Market Value for Allogeneic Stem Cell Therapy, 2018 - 2027, (US$ Mn)
FIG. 14 Global Stem Cell Therapy Market Value for Autologous Stem Cell Therapy, 2018 - 2027, (US$ Mn)
FIG. 15 Global Stem Cell Therapy Market Value Share, by Application, 2018 & 2027 (Value %)
FIG. 16 Global Stem Cell Therapy Market Value for Regenerative Medicine, 2018 - 2027, (US$ Mn)
FIG. 17 Global Stem Cell Therapy Market Value for Drug Discovery & Development, 2018 - 2027, (US$ Mn)
FIG. 18 Global Stem Cell Therapy Market Value Share, by Cell Source, 2018 & 2027 (Value %)
FIG. 19 Global Stem Cell Therapy Market Value for Adipose Tissue-Derived Mesenchymal Stem Cells, 2018 - 2027 (US$ Mn)
FIG. 20 Global Stem Cell Therapy Market Value for Bone Marrow-Derived Mesenchymal Stem Cells, 2018 - 2027 (US$ Mn)
FIG. 21 Global Stem Cell Therapy Market Value for Cord Blood/Embryonic Stem Cells, 2018 - 2027 (US$ Mn)
FIG. 22 Global Stem Cell Therapy Market Value for Others, 2018 - 2027 (US$ Mn)
FIG. 23 Global Stem Cell Therapy Market Value Share, by End-User, 2018 & 2027 (Value %)
FIG. 24 Global Stem Cell Therapy Market Value for Hospitals, 2018 - 2027 (US$ Mn)
FIG. 25 Global Stem Cell Therapy Market Value for Diagnostic Centers, 2018 - 2027 (US$ Mn)
FIG. 26 Global Stem Cell Therapy Market Value for Others, 2018 - 2027 (US$ Mn)
FIG. 27 North America Stem Cell Therapy Market Value, 2018 - 2027, (US$ Mn)
FIG. 28 Europe Stem Cell Therapy Market Value, 2018 - 2027, (US$ Mn)
FIG. 29 Asia Pacific Stem Cell Therapy Market Value, 2018 - 2027, (US$ Mn)
FIG. 30 LATIN America Stem Cell Therapy Market Value, 2018 - 2027, (US$ Mn)
FIG. 31 Middle East & Africa Stem Cell Therapy Market Value, 2018 - 2027, (US$ Mn)
$ 5200/- Multi User License
We understand that every business has unique requirements. This report can be customized based on:
- Deep regional & country-level market intelligence
- Application-specific and end-use industry segmentation
- Competitive landscape & strategic benchmarking
- Go-to-market and expansion strategy insights
- Custom data cuts aligned to your business goals
- Structured Primary Research Framework
- On-Demand Industry Expert Interviews Available
- Dedicated Analyst Support
- Custom Data On Request
- Post-Purchase Strategy Consultation
- Complimentary 30-min Analyst Session
- 30% of Our Clients Are Returning Enterprise Buyers
Our Clients
